All Updates

BATON ROUGE, LA - Yesterday, the American Cancer Society Cancer Action Network (ACS CAN) hosted a policy forum addressing health disparities and its impact on access to care for cancer patients and survivors. The panel discussion included key stakeholders throughout the health community and two elected officials, Sen. Fred Mills

A new survey shows cancer patients and recent survivors have had a positive experience using telehealth in the wake of the pandemic and are willing to use or adapt to using telehealth services in the future.

Statement from American Cancer Society Cancer Action Network (ACS CAN) Government Relations Director Emily Ogden NASHVILLE, TN – “The American Cancer Society’s (ACS) right to make decisions in the best interest of their employees, the cancer patients they serve and the right of cancer patients who have compromised

As Congress prepares to consider the Build Back Better Act , cancer patients, survivors and their caregivers are urging lawmakers to make sure certain key health provisions are included in any final legislation.

As Congress prepares to consider the Build Back Better Act , cancer patients, survivors and their caregivers are urging lawmakers to make sure certain key health provisions are included in any final legislation.

As lawmakers deliberate which health care priorities to include in the budget reconciliation package, ACS CAN is strongly urging Congress and the Administration to once and for all permanently close the Medicaid coverage gap and provide access to quality, affordable coverage to millions of Americans.

CHEYENNE, Wyo.—A new poll released today by the American Cancer Society Cancer Action Network (ACS CAN), AARP, the American Heart Association and American Lung Association shows the majority of Wyoming voters support efforts to increase access to health care by expanding Medicaid. Wyoming is one of 12 states that has

ACS CAN President Lisa Lacasse expresses concern over FDA's approval of four flavored tobacco products.

ACS CAN President Lisa Lacasse expresses concern over FDA's approval of four flavored tobacco products.